|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
Spaulding Rehabilitation Hospital, Boston, MA
Correspondence to: Douglas C. Johnson, MD, Spaulding Rehabilitation Hospital, 125 Nashua St, Boston, MA 02114; e-mail: djohnson5{at}partners.org
To the Editor:
I thank Traynor et al (May 2005)1 for providing data showing the importance of appropriately adjusting the diffusing capacity of the lung for carbon monoxide (DLCO) and DLCO/alveolar volume (VA) ratio for measured lung volume.
DLCO falls and DLCO/VA ratio increases with smaller VA,23 so an unadjusted DLCO underestimates diffusion and an unadjusted DLCO/VA markedly overestimates diffusion at low lung volumes. A method for adjusting DLCO and DLCO/VA ratio for lung volume, which fits the theoretical and empiric data well,2 multiplies predicted DLCO by (0.58 + 0.42*VAfr), and predicted DLCO/VA ratio by (0.42 + 0.58/VAfr), where Vafr is the measured VA/predicted VA ratio. DACO (ie, DLCO adjusted for VA) and KACO (DLCO/VA or KCO adjusted for VA) have the same percentage of the predicted value.
At baseline, the patients of Traynor et al1 with refractory systemic lupus erythematosus had a DLCO of 54% predicted (12% were >80% predicted), a DLCO/VA ratio of 84% predicted (53% were >80% predicted), and DACO and KACO values of 62% predicted (12% were >80% predicted). Two patients increased DLCO by 27% and 18%, but decreased DLCO/VA ratio by 41% and 54% during sustained remissions, with DACO increasing by 15% and 10%. Very different interpretations of lung function occur using percent predicted values for DLCO or DLCO/VA ratio. DACO and KACO provide better assessments of diffusion capacity.
References
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |